High efficacy of the MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis, a 20 year experience

BACKGROUND: Adult Langerhans cell histiocytosis (LCH) is an orphan disease. Chemotherapy is usually reserved to patients presenting with single system multifocal (SS-m) or multisystem (MS) disease but due to the lack of randomized studies no standard first line therapy has been defined yet. Pediatri...

Descripción completa

Detalles Bibliográficos
Autores principales: Derenzini, Enrico, Stefoni, Vittorio, Pellegrini, Cinzia, Gandolfi, Letizia, Broccoli, Alessandro, Casadei, Beatrice, Quirini, Federica, Argnani, Lisa, Tonialini, Lorenzo, Zinzani, Pier Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640159/
https://www.ncbi.nlm.nih.gov/pubmed/26552668
http://dx.doi.org/10.1186/s12885-015-1903-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640159/
https://www.ncbi.nlm.nih.gov/pubmed/26552668
http://dx.doi.org/10.1186/s12885-015-1903-8

Ejemplares similares